Sherwin-Williams Co (SHW) recent quarterly performance of 11.10% is not showing the real picture

Witnessing the stock’s movement on the chart, on Thursday, Sherwin-Williams Co (NYSE: SHW) set off with pace as it heaved 0.86% to $384.00, before settling in for the price of $380.73 at the close. Taking a more long-term approach, SHW posted a 52-week range of $249.49-$392.57.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The Basic Materials Sector giants’ yearly sales growth during the last 5-year period was 5.68%. Meanwhile, its Annual Earning per share during the time was 18.91%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 9.56%. This publicly-traded company’s shares outstanding now amounts to $254.50 million, simultaneously with a float of $231.41 million. The organization now has a market capitalization sitting at $96.71 billion. At the time of writing, stock’s 50-day Moving Average stood at $373.66, while the 200-day Moving Average is $334.55.

Sherwin-Williams Co (SHW) Ownership Facts and Figures

Nothing is more important than checking the behaviour of major investors towards the stock of the Specialty Chemicals industry. Sherwin-Williams Co’s current insider ownership accounts for 8.12%, in contrast to 80.08% institutional ownership. According to the most recent insider trade that took place on Aug 30 ’24, this organization’s SVP – Finance & CFO sold 14,520 shares at the rate of 366.83, making the entire transaction reach 5,326,372 in total value, affecting insider ownership by 63,520. Preceding that transaction, on Aug 30 ’24, Company’s Executive Chairman sold 115,969 for 364.54, making the whole transaction’s value amount to 42,275,050. This particular insider is now the holder of 366,546 in total.

Sherwin-Williams Co (SHW) Earnings and Revenue Records

Sherwin-Williams Co’s EPS increase for this current 12-month fiscal period is 9.56% and is forecasted to reach 12.80 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 10.28% through the next 5 years, which can be compared against the 18.91% growth it accomplished over the previous five years trading on the market.

Sherwin-Williams Co (NYSE: SHW) Trading Performance Indicators

Let’s observe the current performance indicators for Sherwin-Williams Co (SHW). It’s Quick Ratio in the last reported quarter now stands at 0.51. The Stock has managed to achieve an average true range (ATR) of 7.76. Alongside those numbers, its PE Ratio stands at $38.26, and its Beta score is 1.18. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.20. Similarly, its price to free cash flow for trailing twelve months is now 47.23.

In the same vein, SHW’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 10.04, a figure that is expected to reach 2.07 in the next quarter, and analysts are predicting that it will be 12.80 at the market close of one year from today.

Technical Analysis of Sherwin-Williams Co (SHW)

Going through the that latest performance of [Sherwin-Williams Co, SHW]. Its last 5-days volume of 6.09 million indicated improvement to the volume of 1.64 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 83.72% While, its Average True Range was 8.29.

Raw Stochastic average of Sherwin-Williams Co (SHW) in the period of the previous 100 days is set at 91.46%, which indicates a major rise in contrast to 83.58% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 32.41% that was higher than 22.86% volatility it exhibited in the past 100-days period.